Press Releases

< Press Releases
June 2010

Watermark Medical Secures Investment from CA Technologies

BOCA RATON, Fla.–(BUSINESS WIRE)–Watermark Medical, Inc., a privately-held medical products and services company currently servicing the sleep-disordered breathing market, today announced the completion of a $15 million equity investment from CA Technologies (NASDAQ: CA). This equity investment in Watermark Medical represents CA Technologies’ entry into the emerging Software-as-a-Service (SaaS)-based healthcare cloud market. As part of the investment, CA Technologies will hold a minority stake in Watermark Medical and two seats on Watermark’s Board of Directors

Watermark Medical’s current technology enables medical practitioners to easily manage, aggregate and access critical diagnostic and historical patient information. According to Sean Heyniger, CEO of Watermark Medical, “CA Technologies is an expert in managing data in virtual and cloud environments, and this investment will further the development of our advanced, web-based technology platform.”

“We’re excited about working with Watermark Medical to develop innovative solutions for cloudconnected healthcare,” said Jacob Lamm, Executive Vice President of Strategy and Corporate Development at CA Technologies. “This investment provides a significant opportunity for CA Technologies to participate in the future of the management of medical data. With Watermark, we will be working with a company that can take our technology and immediately apply it toward helping improve the quality of care physicians can provide for their patients.”

John Sculley, co-chairman of Watermark’s Board of Directors agrees. “As an emerging leader in the medical cloud computing arena, Watermark is on track to expand the technological capabilities of traditional primary care physician (PCP) offices with our comprehensive cloud platform services,” he said. “With Electronic Medical Records, the growing tele-health industry and a new focus on preventative healthcare, there is more opportunity than ever for technology organizations such as CA Technologies to help drive innovation in the area of data management, aggregation and delivery.”

Watermark Medical already has seen success with its premiere product offering, the Watermark ARES device. The Watermark ARES (Apnea Risk Evaluation System) is the first FDA-cleared, CMS approved, in-home, wire-free, ambulatory sleep test device that provides medical practitioners with a highly accurate, lower-cost tool to diagnose patients who may be suffering from Obstructive Sleep Apnea (OSA). This comprehensive diagnostic system is already transforming the diagnostic treatment and care of OSA with its end-to-end, diagnostic-to-therapy platform service.

According to Heyniger, “as Watermark’s technology expands and is increasingly incorporated into the day-to-day functions of the medical community, benefits will include: a decrease in costs to the physician and patients; ability for patients to gain access to potentially lifesaving diagnostic tests; shifting the cost burden from expensive hospital and specialist-based testing to the PCP; and increasing accuracy in tracking the long term health and wellness of patients.”

About Watermark Medical

Watermark Medical, Inc., (WM) is a privately held medical products company servicing the sleep-disordered breathing market. Its co-founders/investors are serial entrepreneurs with extensive experience building successful business models and sales and distribution channels for medical services. WM’s recent experience was with CardioNet, Inc. (NASDAQ:BEAT), a reimbursement- based, medical services company focused on cardiac arrhythmia monitoring. The company is headquartered in Boca Raton, FL. For more information, visit

About CA

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments – from mainframe and physical, to virtual and cloud. CA Technologies manages and secures IT environments and enables customers to deliver more flexible IT services. CA Technologies’ innovative products and services provide the insight and control essential for IT organizations to power business agility. The majority of the Global Fortune 500 relies on CA Technologies to manage their evolving IT ecosystems. For additional information, visit CA Technologies at Follow CA Technologies on Twitter at

Cautionary Statement

Certain statements in this communication (such as statements containing the words “believes,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) constitute “forward-looking statements” that are based upon the beliefs of, and assumptions made by, CA Technologies’ management, as well as information currently available to management. These forwardlooking statements reflect CA Technologies’ current views with respect to future events and are subject to certain risks, uncertainties, and assumptions. A number of important factors could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: global economic factors or political events beyond CA Technologies’ control; general economic conditions, including concerns regarding a global recession and credit constraints, or unfavorable economic conditions in a particular region, industry or business sector; impact of revenue recognition accounting policies on operating results; failure to expand channel partner programs; ability to adequately manage and evolve financial reporting and managerial systems and processes; ability to successfully integrate acquired companies and products into existing businesses; competition in product and service offerings and pricing; ability to retain and attract qualified key personnel; rapid technological and market changes; dependence on third party operating systems and software; use of software from open source code sources; discovery of errors in CA Technologies’ software and potential product liability claims; significant amounts of debt and possible future credit rating changes; the failure to protect CA Technologies’ intellectual property rights and source code; the timing of orders from customers and channel partners; reliance upon large transactions with customers; sales to government customers; breaches of CA Technologies’ software products and CA Technologies’ and customers’ data centers and IT environments; lack of market growth in key product areas; use of third party microcode; third party claims of intellectual property infringement or royalty payments; fluctuations in foreign currencies; failure to successfully execute restructuring plans and related sales model changes; successful outsourcing of various functions to third parties; potential tax liabilities; and these factors and the other factors described more fully in CA Technologies’ filings with the Securities and Exchange Commission. CA Technologies assumes no obligation to update the information in this communication, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

View Pdf